- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07102953
How Different Meditation Styles Boost Creativity in Researchers
This clinical trial explores how two types of meditation - focused attention and open monitoring - may enhance creativity in scientific researchers. The study compares these meditation techniques against a control group listening to creativity-themed stories.
Who can participate:
- Graduate students (Master's or PhD candidates)
- Research staff including postdocs and academic researchers
- Adults aged 18-65 without severe mental health conditions
What participants will do:
Researchers will randomly assign volunteers to one of three groups for a 5-day practice period:
- Focused attention meditation: Concentrating on breathing
- Open monitoring meditation: Maintaining broad awareness
- Control group: Listening to creativity stories
Key measurements include:
- Creative thinking tests (finding multiple uses for objects and word association)
- Brain activity scans (EEG) to track neurological changes
- Mindfulness and mental health questionnaires
- Attention performance tests
Why this matters:
Scientific research demands high levels of creativity for problem-solving and innovation. This study could reveal practical meditation techniques to enhance researchers' cognitive flexibility and idea generation. Previous studies suggest meditation may improve focus and reduce stress, but its specific impact on creative thinking in academic settings remains underexplored.
For caregivers and family members of researchers, understanding these potential benefits could help support loved ones facing the intense mental demands of academic work. The study's focus on short, practical interventions (just 15 minutes daily) makes findings potentially applicable to busy professionals.
The research also examines whether meditation effects persist after the training period, with follow-up tests scheduled one month later. This could indicate whether brief meditation practices create lasting changes in creative thinking patterns.
By comparing two distinct meditation styles, the study may help individuals choose the most effective practice for their needs. The inclusion of EEG measurements provides objective data on how meditation physically affects the brain during creative tasks.
Mental health assessments throughout the study will monitor for any reductions in anxiety or depression symptoms, potentially offering additional benefits beyond creativity enhancement. The research team includes experts from multiple Chinese universities, ensuring rigorous methodology and diverse perspectives.
This investigation builds on growing evidence that mind-body practices can enhance cognitive performance. Results could influence workplace wellness programs in research institutions and potentially other knowledge-intensive professions. The study's focus on young and mid-career researchers makes findings particularly relevant for current academic professionals.
For patients considering meditation practices, this research contributes to understanding how different techniques affect specific mental capacities. The careful screening process and controlled conditions help ensure reliable results that could guide personal practice decisions.
The study represents an innovative intersection of contemplative practices and scientific creativity research. Its findings may inspire new approaches to fostering innovation in academic and professional settings while supporting mental wellbeing.
Upcoming Clinical Trials
-
NCT07826949Not yet recruitingGlioma | Brain Neoplasm | Recurrent High-Grade Gliomas
-
NCT07826962Not yet recruiting
-
NCT07826975Not yet recruiting
-
NCT07826988Not yet recruitingSickle Cell Disease | Vaso-occlusive Crisis
-
NCT07827001RecruitingBrain Cancer | CNS Cancer | Nervous System Cancer | Brain Cancer Metastatic
-
NCT07827027Not yet recruiting
-
NCT07827040RecruitingAdults | Low Vision Digital Assistance | Visual Impairments
-
NCT07827053Not yet recruitingPancreatic Ductal Adenocarcinoma (PDAC)
-
NCT07827066Not yet recruitingSmoking Cessation | AI Agent | Early-Stage Cancer
-
NCT07827131Not yet recruiting